연구성과로 돌아가기

2020 연구성과 (109 / 270)

※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
WoS SCOPUS Document Type Document Title Abstract Authors Affiliation ResearcherID (WoS) AuthorsID (SCOPUS) Author Email(s) Journal Name JCR Abbreviation ISSN eISSN Volume Issue WoS Edition WoS Category JCR Year IF JCR (%) FWCI FWCI Update Date WoS Citation SCOPUS Citation Keywords (WoS) KeywordsPlus (WoS) Keywords (SCOPUS) KeywordsPlus (SCOPUS) Language Publication Stage Publication Year Publication Date DOI JCR Link DOI Link WOS Link SCOPUS Link
Article A matching prior based on the modified profile likelihood for the common mean in multiple log-normal distributions In this paper, we develop a matching prior for the common mean in several log-normal distributions. For this problem, assigning priors appropriately for the common log-normal mean is challenging owing to the presence of nuisance parameters. Matching priors, which are priors that match the posterior probabilities of certain regions within their frequentist coverage probabilities, are commonly used in this problem. However, a closed form posterior under the derived first order matching prior is not available; further, the second order matching prior is difficult to be derived in this problem. Thus, alternatively, we derive a matching prior based on a modification of the profile likelihood. Simulation studies show that this proposed prior meets the target coverage probabilities very well even for small sample sizes. Finally, we present a real example. Kim, Yongku; Lee, Woo Dong; Kang, Sang Gil Kyungpook Natl Univ, Dept Stat, Daegu 41566, South Korea; Daegu Haany Univ, Dept Data Management, Kyungsan 38610, South Korea; Sangji Univ, Dept Comp & Data Informat, Wonju 26339, South Korea 47962102500; 8328822200; 56119861400 kim.1252@knu.ac.kr;wdlee@dhu.ac.kr;sangkg@sangji.ac.kr; STATISTICAL PAPERS STAT PAP 0932-5026 1613-9798 61 2 SCIE STATISTICS & PROBABILITY 2020 2.234 29.2 0.29 2025-06-25 2 2 Matching prior; Modified profile likelihood; Common log-normal mean CONFIDENCE-INTERVALS; NONINFORMATIVE PRIORS; INFERENCE Common log-normal mean; Matching prior; Modified profile likelihood English 2020 2020-04 10.1007/s00362-017-0950-4 바로가기 바로가기 바로가기 바로가기
Article COVID-19 transmission and blood transfusion: A case report The recent outbreak of the novel coronavirus disease 2019 (COVID-19) has been labelled as a pandemic by the World Health Organization. Although person-to-person transmission of the etiologic agent, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been confirmed, it is not known whether COVID-19 may be transmitted by blood transfusion. Notwithstanding the urgent requirement of blood, it is critical to know whether the SARS-CoV-2 virus can be transmitted by blood transfusion because many individuals may be asymptomatic carriers and may donate blood. Several cases in which specific viral RNA could be detected in the serum from patients with COVID-19 have already been reported; these findings suggest that blood donation may be an unexplored route of transmission. However, the American Association of Blood Banks and Centers for Disease Control and Prevention have not recommended any specific SARS-CoV-2-related actions to be taken at blood collection centres at this time. In this report, we describe a case of a 21-year-old man with very severe aplastic anaemia who received apheresis platelet transfusion from an individual who was subsequently diagnosed with COVID-19. Our patient tested negative for COVID-19 and is awaiting allogeneic stem cell transplantation. (C) 2020 The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences. Cho, Hee Jeong; Koo, Ji Wan; Roh, Soong Ki; Kim, Yu Kyung; Suh, Jang Soo; Moon, Joon Ho; Sohn, Sang Kyun; Baek, Dong Won Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Internal Med, Daegu, South Korea; Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Hematol Oncol, 130 Dongdeok Ro, Daegu 41944, South Korea; Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Lab Med, Daegu, South Korea Kim, Young-Il/ISS-7678-2023 57216754907; 57216743634; 57209411088; 9237571900; 57201729629; 56568642700; 13310226800; 57191874272 baekdw83@gmail.com; JOURNAL OF INFECTION AND PUBLIC HEALTH J INFECT PUBLIC HEAL 1876-0341 1876-035X 13 11 SCIE INFECTIOUS DISEASES;PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH 2020 3.718 29.3 5.55 2025-06-25 70 80 Blood transfusion; Coronavirus; COVID-19; Viremia; Transmission Blood transfusion; Coronavirus; COVID-19; Transmission; Viremia Betacoronavirus; Blood Component Removal; Blood Donors; Blood Platelets; Blood Transfusion; Coronavirus Infections; Humans; Male; Pandemics; Pneumonia, Viral; Young Adult; cyclosporine; thymocyte antibody; adult; allogeneic hematopoietic stem cell transplantation; apheresis; aplastic anemia; Article; blood donor; case report; clinical article; clinical outcome; coronavirus disease 2019; disease severity; epistaxis; human; immunosuppressive treatment; male; petechia; priority journal; real time reverse transcription polymerase chain reaction; thrombocyte transfusion; virus transmission; young adult; Betacoronavirus; blood donor; blood transfusion; Coronavirus infection; pandemic; thrombocyte; virus pneumonia English 2020 2020-11 10.1016/j.jiph.2020.05.001 바로가기 바로가기 바로가기 바로가기
Article Dehydrogenation of pure methanol in an alkaline solution using copper electrodes Herein, we focused on electrolysis to produce hydrogen-based energy to reduce pollution and cost of energy generation by replacing platinum (Pt) and ruthenium (Ru) anodes with copper (Cu) anodes, while demonstrating that H2 and CO can be obtained by dehydrogenating pure methanol in a non-compartment cell. Also this is a new study that is completely different from DMFC. Redox products of methanol and electrochemical efficiency were determined using various techniques. 1 V (vs Ag/AgCl [KCl sat']) was applied to quantitatively evaluate H-2 generation; on average, 801.17 mmol g(-1) L-1 h(-1) of H-2 was generated. The Cu electrode was electrochemically stable under the stirring at 150 rpm, indicating reduced toxicity by CO adsorption. Gas-phase CO and H-2, along with liquid- phase formate, carbonate, and paraformaldehyde, were obtained; the main product was H-2. However, details of the dehydrogenation mechanism remain unclear, and merit further investigations. (C) 2020 Hydrogen Energy Publications LLC. Published by Elsevier Ltd. All rights reserved. Woo, Sang-Won; Kim, Chan-Soo; Lee, Sung-Eun; Kim, Tae-Oh Kumoh Natl Inst Technol, Coll Civil & Environm Engn, Gumi 39253, South Korea; Korea Inst Energy Res, Jeju Global Res Ctr, Marine Energy Convergence & Integrat Lab, Jeju, South Korea; Kyungpook Natl Univ, Sch Appl Biosci, Daegu 41566, South Korea; Kumoh Natl Inst Technol, Dept Environm Engn, Gumi 39177, South Korea; Kumoh Natl Inst Technol, Dept Energy Engn Convergence, Gumi 39177, South Korea Kim, Taeoh/F-4647-2012 57219210124; 7409872719; 55890041600; 9335312200 selpest@knu.ac.kr;tokim@kumoh.ac.kr; INTERNATIONAL JOURNAL OF HYDROGEN ENERGY INT J HYDROGEN ENERG 0360-3199 1879-3487 45 56 SCIE CHEMISTRY, PHYSICAL;ELECTROCHEMISTRY;ENERGY & FUELS 2020 5.816 29.3 0.13 2025-06-25 2 2 Pure methanol; Dehydrogenation; Cu electrodes; Alkaline; Electrolysis ELECTROCATALYTIC OXIDATION; HYDROGEN-PRODUCTION; CO2; ELECTROOXIDATION; OXIDE; CU Alkaline; Cu electrodes; Dehydrogenation; Electrolysis; Pure methanol Acetal resins; Anodes; Copper; Copper compounds; Dehydrogenation; Methanol; Potassium compounds; Alkaline solutions; CO adsorption; Copper electrodes; Cost of energies; Cu electrode; Paraformaldehydes; Pure methanols; Reduced toxicity; Direct methanol fuel cells (DMFC) English 2020 2020-11-13 10.1016/j.ijhydene.2020.08.228 바로가기 바로가기 바로가기 바로가기
Article Does Carboplatin Rapid Desensitization Change Its Adverse Drug Reactions Other than Hypersensitivity and Efficacy in Patients With Ovarian Cancer? Purpose: Rapid drug desensitization is known to be a good strategy in patients with drug hypersensitivity to chemotherapy. However, changes in maximal drug concentration and exposure time in blood through desensitization may alter other adverse reactions and efficacy of the drug. We investigated rapid desensitization for carboplatin in terms of severe adverse drug reactions (ADRs) and efficacy compared with the standard infusion. Methods: A retrospective cohort study was conducted on patients with recurrent ovarian cancer who received carboplatin chemotherapy from 2017 to 2019. We compared serious adverse events (SAEs), ADRs according to organ classes, time to progression (TTP), and overall survival (OS). Results: Of 108 desensitization procedures performed in 21 patients, 104 were successfully accomplished (96.3%). There were compared with 271 procedures in 41 patients who received the standard infusion method. There were 8 (7.7%) SAEs in the rapid desensitization group and 34 (12.5%) in the control group. One drug-related death occurred in the rapid desensitization group. In the rapid desensitized group, except for neutropenia, there was no statistically significant increase in SAEs and over grade 3 of ADRs according to organ classes compared with the control group. In the efficacy analysis, TTP and OS were similar in the 2 groups. Conclusions: Rapid desensitization of carboplatin can lower the risk of immediate hypersensitivity reactions without changing the inherent effect and severe ADRs. Park, Han-Ki; Lee, Soo Jung; Kim, Sujeong; Lee, Jong-Myung; Hong, Dae Gy Kyungpook Natl Univ, Sch Med, Dept Allergy & Clin Immunol, Daegu, South Korea; Kyungpook Natl Univ, Sch Med, Dept Oncol, Daegu, South Korea; Kyungpook Natl Univ, Sch Med, Dept Obstet & Gynecol, Daegu, South Korea ; Park, Han-Ki/AAY-3102-2020; Kim, Ju-Hyoung/N-1450-2019 57218664064; 57203597252; 36666447400; 36123106800; 26656670100 haan33@gmail.com;sj.lee@knu.ac.kr; ALLERGY ASTHMA & IMMUNOLOGY RESEARCH ALLERGY ASTHMA IMMUN 2092-7355 2092-7363 12 6 SCIE ALLERGY;IMMUNOLOGY 2020 5.764 29.3 0.37 2025-06-25 10 10 Desensitization; hypersensitivity; antineoplastic agents; carboplatin; drug-related side effects and adverse reactions; drug effects; survival; ovarian neoplasm RISK STRATIFICATION; CLINICAL-FEATURES; CHEMOTHERAPY; GEMCITABINE; CISPLATIN; TOXICITY Antineoplastic agents; Carboplatin; Desensitization; Drug effects; Drug-related side effects and adverse reactions; Hypersensitivity; Ovarian neoplasm; Survival bevacizumab; carboplatin; chlorpheniramine; dexamethasone; fexofenadine; gemcitabine; montelukast; paclitaxel; adult; adverse drug reaction; anemia; Article; cancer combination chemotherapy; cancer survival; cohort analysis; controlled study; cytoreductive surgery; desensitization; drug efficacy; drug hypersensitivity; female; gastrointestinal disease; human; infection; infestation; liver toxicity; major clinical study; nausea; nephrotoxicity; neurologic disease; neutropenia; nutritional disorder; ovary cancer; overall survival; retrospective study; thrombocytopenia English 2020 2020-11 10.4168/aair.2020.12.6.1046 바로가기 바로가기 바로가기 바로가기
Letter Management of Severe Asthma During the COVID-19 Pandemic in Korea Kim, Sujeong; Jin, Hyun Jung; Kim, So Ri Kyungpook Natl Univ, Sch Med, Div Allergy & Infect Dis, Dept Internal Med, Daegu, South Korea; Yeungnam Univ, Yeungnam Univ & Resp Ctr, Div Pulm & Allergy, Dept Internal Med,Coll Med,Med Ctr, Daegu, South Korea; Jeonbuk Natl Univ, Div Resp Med & Allergy, Dept Internal Med, Res Ctr Pulm Disorders,Med Sch, Jeonju, South Korea Kim, Ju-Hyoung/N-1450-2019; Kim, So/AAS-1630-2021; Jin, Hyunjung/MHR-8031-2025 36666447400; 36157127500; 25637561400 sori@jbnu.ac.kr; ALLERGY ASTHMA & IMMUNOLOGY RESEARCH ALLERGY ASTHMA IMMUN 2092-7355 2092-7363 12 5 SCIE ALLERGY;IMMUNOLOGY 2020 5.764 29.3 0.08 2025-06-25 1 1 English 2020 2020-09 10.4168/aair.2020.12.5.897 바로가기 바로가기 바로가기 바로가기
Article; Proceedings Paper One-pot synthesis of Cu-TiO2/CuO nanocomposite: Application to photocatalysis for enhanced H2 production, dye degradation & detoxification of Cr (VI) Photocatalytic hydrogen production under the visible spectrum of solar light is an important topic of research. To achieve the targeted visible light hydrogen production and improve the charge carrier utilization, bandgap engineering and surface modification of the photocatalyst plays a vital role. Present work reports the one-pot synthesis of Cu TiO2/CuO nanocomposite photocatalyst using green surfactant -aided -ultrasonication method. The materials characterization data reveals the TiO2 particle size of 20-25 nm and the existence of copper in the lattice as well as in the surface of anatase TiO2. This is expected to facilitate better optical and surface properties. The optimized photocatalyst shows enhanced H-2 production rate of 10,453 mu mol h(-1) g(-1) of the catalyst which is 21 fold higher than pure TiO2 nanoparticles. The photocatalyst was tested for degradation of methylene blue dye (90% in 4 h) in aqueous solution and photocatalytic reduction of toxic Cr6+ ions (55% in 4 h) in aqueous solution. A plausible mechanistic pathway is also proposed. (C) 2019 Hydrogen Energy Publications LLC. Published by Elsevier Ltd. All rights reserved. Udayabhanu; Reddy, N. Lakshmana; Shankar, M. V.; Sharma, S. C.; Nagaraju, G. Siddaganga Inst Technol, Dept Chem, Energy Mat Res Lab, Tumkur 572103, India; Yogi Vemana Univ, Dept Mat Sci & Nanotechnol, Nanocatalysis & Solar Fuels Res Lab, Kadapa 516005, Andhra Pradesh, India; Kyungpook Natl Univ, Sch Nano & Mat Sci & Engn, Dept Energy Chem Engn, 2559 Gyeongsang Daero, Sangju 37224, South Korea; Jain Univ, Dept Mech Engn, Bengaluru, India; Visvesvaraya Technol Univ, Belagavi, India Muthukonds Venkatakrishnan, Shankar/AAC-1460-2019; N, Dr. Lakshmana Reddy/K-2238-2019; Venkatakrishnan, Shankar/AAC-1460-2019; Sharma, Sourabh/GRF-1624-2022; Nagappagari, Lakshmana Reddy/K-2238-2019 56429682600; 56499352000; 7005167181; 55702520600; 21743102700 nagarajugn@gmail.com; INTERNATIONAL JOURNAL OF HYDROGEN ENERGY INT J HYDROGEN ENERG 0360-3199 1879-3487 45 13 SCIE CHEMISTRY, PHYSICAL;ELECTROCHEMISTRY;ENERGY & FUELS 2020 5.816 29.3 3.15 2025-06-25 55 80 Sonication; Copper; Titanium dioxide; Hydrogen generation; Dye degradation; Chromium reduction DOPED TIO2 NANOPARTICLES; REDUCED GRAPHENE OXIDE; HYDROGEN-PRODUCTION; VISIBLE-LIGHT; WATER; CUO; HETEROJUNCTION; GENERATION; CUO/TIO2; NANORODS Chromium reduction; Copper; Dye degradation; Hydrogen generation; Sonication; Titanium dioxide Aromatic compounds; Chromium compounds; Copper; Detoxification; Dyes; Light; Nanocomposites; Particle size; Solar power generation; Sonication; TiO2 nanoparticles; Titanium dioxide; Band gap engineering; Chromium reduction; Dye degradation; Hydrogen generations; Materials characterization; Mechanistic pathways; Photocatalytic hydrogen production; Photocatalytic reduction; Hydrogen production English 2020 2020-03-06 10.1016/j.ijhydene.2019.10.081 바로가기 바로가기 바로가기 바로가기
Review The KAAACI/KDA Evidence-Based Practice Guidelines for Chronic Spontaneous Urticaria in Korean Adults and Children: Part 1. Definition, Methodology and First-line Management Chronic spontaneous urticaria (CSU) is defined as the occurrence of spontaneous wheals, angioedema, or both for >6 weeks in the absence of specific causes. It is a common condition associated with substantial disease burden both for affected individuals and societies in many countries, including Korea. CSU frequently persists for several years and requires high-intensity treatment; therefore, patients experience deteriorations in quality of life and medication-associated complications. During the last decade, there have been major advances in the pharmacological treatment of CSU and there is an outstanding need for evidence-based guidelines that reflect clinical practice in Korea. The guidelines reported here represent a joint initiative of the Korean Academy of Asthma, Allergy and Clinical Immunology and the Korean Dermatological Association, and aim to provide evidence-based guidance for the management of CSU in Korean adults and children. In Part 1, disease definition, guideline scope and development methodology as well as evidence-based recommendations on the use of antihistamines and corticosteroids are summarized. Song, Woo-Jung; Choi, Mira; Lee, Dong Hun; Kwon, Jae-Woo; Kim, Gun-Woo; Kim, Myung Hwa; Kim, Mi-Ae; Kim, Min-Hye; Kim, Byung-Keun; Kim, Sujeong; Kim, Joung Soo; Kim, Jung Eun; Kim, Ju-Young; Kim, Joo-Hee; Kim, Hyun Jung; Kim, Hye One; Kim, Hyo-Bin; Roh, Joo Young; Park, Kyung Hee; Park, Kui Young; Park, Han-Ki; Park, Hyunsun; Bae, Jung Min; Byun, Ji Yeon; Song, Dae Jin; Ahn, Young Min; Lee, Seung Eun; Lee, Young Bok; Lee, Joong Sun; Lee, Ji Hyun; Lim, Kyung-Hwan; Ye, Young-Min; Chang, Yoon-Seok; Jeon, You Hoon; Jeon, Jiehyun; Jue, Mihn-Sook; Choi, Sun Hee; Choi, Jeong-Hee; Hur, Gyu-Young; Park, Young Min; Lim, Dae Hyun; Youn, Sang Woong Univ Ulsan, Asan Med Ctr, Coll Med, Dept Allergy & Clin Immunol, Seoul, South Korea; Inje Univ, Ilsan Paik Hosp, Dept Dermatol, Ilsan, South Korea; Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Dept Dermatol, Seoul, South Korea; Kangwon Natl Univ, Sch Med, Dept Internal Med, Chunchon, South Korea; St Carollo Gen Hosp, Dept Internal Med, Sunchon, South Korea; Dankook Univ, Coll Med, Dept Dermatol, Cheonan, South Korea; CHA Univ, CHA Bundang Med Ctr, Dept Pulmonol, Seongnam, South Korea; Ewha Womans Univ, Coll Med, Dept Internal Med, Seoul, South Korea; Korea Univ, Anam Hosp, Med Ctr, Dept Internal Med, Seoul, South Korea; Kyungpook Natl Univ, Sch Med, Dept Internal Med, Daegu, South Korea; Hanyang Univ, Guri Hosp, Dept Dermatol, Guri, South Korea; Catholic Univ Korea, Eunpyeong St Marys Hosp, Dept Dermatol, Seoul, South Korea; Gyeongsang Natl Univ, Changwon Hosp, Dept Internal Med, Div Pulmonol & Allergy, Chang Won, South Korea; Hallym Univ, Sacred Heart Hosp, Coll Med, Dept Med,Div Pulm Allergy & Crit Care Med, Anyang, South Korea; Korea Univ, Coll Med, Inst Evidence Based Med, Dept Prevent Med, Seoul, South Korea; Hallym Univ, Coll Med, Dept Dermatol, Seoul, South Korea; Inje Univ, Sanggye Paik Hosp, Dept Pediat, Seoul, South Korea; Gachon Univ, Gil Med Ctr, Sch Med, Dept Dermatol, Incheon, South Korea; Yonsei Univ, Coll Med, Dept Internal Med, Div Allergy & Immunol, Seoul, South Korea; Chung Ang Univ, Coll Med, Dept Dermatol, Seoul, South Korea; Kyungpook Natl Univ, Chilgok Hosp, Sch Med, Dept Allergy & Clin Immunol, Daegu, South Korea; SMG SNU Boramae Med Ctr, Dept Dermatol, Seoul, South Korea; Catholic Univ Korea, St Vincents Hosp, Coll Med, Dept Dermatol, Suwon, South Korea; Ewha Womans Univ, Coll Med, Dept Dermatol, Seoul, South Korea; Korea Univ, Coll Med, Dept Pediat, Seoul, South Korea; Eulji Univ, Eulji Gen Hosp, Sch Med, Dept Pediat, Seoul, South Korea; Pusan Natl Univ, Yangsan Hosp, Dept Internal Med, Div Pulmonol & Allergy, Yangsan, South Korea; Catholic Univ Korea, Coll Med, Dept Dermatol, Seoul, South Korea; Eulji Univ, Sch Med, Dept Dermatol, Daejeon, South Korea; Catholic Univ Korea, Seoul St Marys Hosp, Dept Dermatol, Coll Med,Brain Korea 21 Plus Project Med Sci, Seoul, South Korea; Wirye Seoul Doctors Hosp, Seongnam, South Korea; Ajou Univ, Sch Med, Dept Allergy & Clin Immunol, Suwon, South Korea; Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Internal Med, Seongnam, South Korea; Hallym Univ, Dongtan Sacred Heart Hosp, Dept Pediat, Hwaseong, South Korea; Korea Univ, Coll Med, Dept Dermatol, Seoul, South Korea; Vet Hlth Serv Med Ctr, Dept Dermatol, Seoul, South Korea; Kyung Hee Univ, Sch Med, Kyung Hee Univ Hosp Gangdong, Dept Pediat, Seoul, South Korea; Hallym Univ, Dongtan Sacred Heart Hosp, Dept Pulmonol & Allergy, Hwaseong, South Korea; Hallym Univ, Coll Med, Allergy & Clin Immunol Res Ctr, Chunchon, South Korea; Korea Univ, Coll Med, Dept Internal Med, Seoul, South Korea; Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Dermatol, Seoul, South Korea; Inha Univ, Sch Med, Dept Pediat, Incheon, South Korea; Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Dermatol, 82 Gumi Ro,173beon Gil, Seongnam 13620, South Korea Park, Kui Young/JVM-7652-2024; LEE, YOUNG BOK/AAZ-6426-2021; Kim, Byung-Keun/N-4256-2018; Kim, Hak-Jae/Q-9368-2019; Youn, Sang/J-5558-2012; Chang, Yoon-Seok/J-5628-2012; Kim, Juhee/KFS-3069-2024; Park, Han-Ki/AAY-3102-2020; Kim, Ju-Hyoung/N-1450-2019; Kim, Dae/AAJ-7518-2021; Kim, Sara/F-2951-2013; Lee, Dong Hun/AAS-6021-2021; Kang, Sung-Yoon/AAG-7523-2020; Lee, Young Bok/AAZ-6426-2021; Kim, Hye/AAF-7609-2020; Kim, Gou/AAI-1109-2020; Lee, Seung Eun/ABG-1607-2021; Kim, Yong-Tae/HQZ-0240-2023; Kim, Hyun/D-5568-2011 37062104600; 7402093768; 55649570908; 57204538197; 57202669769; 56192953300; 38260929400; 58045929900; 36608393400; 36666447400; 35102450900; 57196356574; 57203326373; 57191685789; 56703907300; 8659715100; 57191720302; 55429683200; 57035517300; 23020014500; 57218664064; 23103922300; 57210714585; 15724462400; 7402443711; 56735321800; 57202327298; 36066866100; 8413361800; 57190277285; 56045433800; 13405438300; 55712986100; 26537543200; 7202411345; 35102158500; 55736569100; 7501395695; 7004193730; 55356320800; 8409118500; 8903096500 dhnlim@naver.com;swyoun@snu.ac.kr; ALLERGY ASTHMA & IMMUNOLOGY RESEARCH ALLERGY ASTHMA IMMUN 2092-7355 2092-7363 12 4 SCIE ALLERGY;IMMUNOLOGY 2020 5.764 29.3 0.4 2025-06-25 17 18 Urticaria; guideline; disease management; therapeutics CHRONIC IDIOPATHIC URTICARIA; QUALITY-OF-LIFE; DOUBLE-BLIND; NONSEDATING ANTIHISTAMINES; PROGNOSTIC-FACTORS; CONTROLLED-TRIAL; EPIDEMIOLOGY; CETIRIZINE; PLACEBO; NATIONWIDE Disease management; Guideline; Therapeutics; Urticaria antihistaminic agent; corticosteroid; cyclosporine; dapsone; immunomodulating agent; leukotriene receptor blocking agent; methotrexate; omalizumab; chronic urticaria; evidence based practice; health care cost; human; Korea; Korean (people); medical society; methodology; phototherapy; practice guideline; quality of life; Review; treatment planning; unmet medical need English 2020 2020-07 10.4168/aair.2020.12.4.563 바로가기 바로가기 바로가기 바로가기
Review The KAAACI/KDA Evidence-Based Practice Guidelines for Chronic Spontaneous Urticaria in Korean Adults and Children: Part 2. Management of H1-Antihistamine-Refractory Chronic Urticaria Quite a few patients with chronic spontaneous urticaria (CSU) are refractory to H-1-antihistamines, even though the dose of H-1-antihistamines is increased up to 4-fold. CSU that is not controlled with H-1-antihistamines results in increased disease burden. Several immunomodulators have been used to manage these patients. The guidelines reported herein are connected to Part 1 of the KAAACI/KDA Evidence-Based Practice Guidelines for Chronic Spontaneous Urticaria in Korean Adults and Children, and aimed to provide evidence-based recommendations for the management of H-1-antihistamine-refractory CSU. Part 2 focuses on the more commonly used additional treatment options for refractory CSU, including omalizumab, cyclosporine, leukotriene receptor antagonist, dapsone, methotrexate, and phototherapy. The evidence to support their efficacy, dosing, safety, and selection of these agents is systematically reviewed. To date, for patients with refractory CSU, the methodologically sound data to evaluate the use of omalizumab has been growing; however, the evidence of other immunomodulators and phototherapy is still insufficient. Therefore, an individualized stepwise approach with a goal of achieving complete symptom control and minimizing side effects can be recommended. Larger controlled studies are needed to elevate the level of evidence to select a rational therapeutic agent for patients with refractory CSU. Choi, Jeong-Hee; Lee, Dong Hun; Song, Woo-Jung; Choi, Mira; Kwon, Jae-Woo; Kim, Gun-Woo; Kim, Myung Hwa; Kim, Mi-Ae; Kim, Min-Hye; Kim, Byung-Keun; Kim, Sujeong; Kim, Joung Soo; Kim, Jung Eun; Kim, Ju-Young; Kim, Joo-Hee; Kim, Hyun Jung; Kim, Hye One; Kim, Hyo-Bin; Roh, Joo Young; Park, Kyung Hee; Park, Kui Young; Park, Han-Ki; Park, Hyunsun; Bae, Jung Min; Byun, Ji Yeon; Song, Dae Jin; Ahn, Young Min; Lee, Seung Eun; Lee, Young Bok; Lee, Joong Sun; Lee, Ji Hyun; Lim, Kyung-Hwan; Youn, Sang Woong; Chang, Yoon-Seok; Jeon, You Hoon; Jeon, Jiehyun; Jue, Mihn-Sook; Choi, Sun Hee; Hur, Gyu-Young; Lim, Dae Hyun; Ye, Young-Min; Park, Young Min Hallym Univ, Dongtan Sacred Heart Hosp, Dept Pulmonol & Allergy, Allergy & Clin Immunol Res Ctr,Coll Med, Chunchon, South Korea; Seoul Natl Univ, Seoul Natl Univ Hosp, Dept Dermatol, Coll Med, Seoul, South Korea; Univ Ulsan, Asan Med Ctr, Dept Allergy & Clin Immunol, Coll Med, Seoul, South Korea; Inje Univ, Ilsan Paik Hosp, Dept Dermatol, Ilsan, South Korea; Kangwon Natl Univ, Sch Med, Dept Internal Med, Chunchon, South Korea; St Carollo Gen Hosp, Dept Internal Med, Sunchon, South Korea; Dankook Univ, Coll Med, Dept Dermatol, Cheonan, South Korea; CHA Univ, CHA Bundang Med Ctr, Dept Pulmonol Allergy & Crit Care Med, Seongnam, South Korea; Ewha Womans Univ, Coll Med, Dept Internal Med, Seoul, South Korea; Korea Univ, Anam Hosp, Dept Internal Med, Med Ctr, Seoul, South Korea; Kyungpook Natl Univ, Sch Med, Dept Internal Med, Daegu, South Korea; Hanyang Univ, Guri Hosp, Dept Dermatol, Guri, South Korea; Catholic Univ Korea, Eunpyeong St Marys Hosp, Coll Med, Dept Dermatol, Seoul, South Korea; Gyeongsang Natl Univ, Changwon Hosp, Dept Internal Med, Div Pulmonol & Allergy, Chang Won, South Korea; Hallym Univ, Sacred Heart Hosp, Div Pulm Allergy & Crit Care Med, Dept Med,Coll Med, Anyang, South Korea; Korea Univ, Coll Med, Dept Prevent Med, Inst Evidence Based Med, Seoul, South Korea; Hallym Univ, Coll Med, Dept Dermatol, Seoul, South Korea; Inje Univ, Sanggye Paik Hosp, Dept Pediat, Seoul, South Korea; Gachon Univ, Sch Med, Dept Dermatol, Gil Med Ctr, Incheon, South Korea; Yonsei Univ, Dept Internal Med, Coll Med, Div Allergy & Immunol, Seoul, South Korea; Chung Ang Univ, Dept Dermatol, Coll Med, Seoul, South Korea; Kyungpook Natl Univ, Chilgok Hosp, Dept Allergy & Clin Immunol, Sch Med, Daegu, South Korea; SMG SNU Boramae Med Ctr, Dept Dermatol, Seoul, South Korea; Catholic Univ Korea, St Vincents Hosp, Coll Med, Dept Dermatol, Suwon, South Korea; Ewha Womans Univ, Dept Dermatol, Coll Med, Seoul, South Korea; Korea Univ, Dept Pediat, Coll Med, Seoul, South Korea; Eulji Univ, Dept Pediat, Coll Med, Eulji Gen Hosp, Seoul, South Korea; Pusan Natl Univ, Yangsan Hosp, Dept Internal Med, Div Pulmonol & Allergy, Yangsan, South Korea; Catholic Univ Korea, Coll Med, Dept Dermatol, Seoul, South Korea; Eulji Univ, Sch Med, Dept Dermatol, Daejeon, South Korea; Catholic Univ Korea, Brain Korea 21 PLUS Project Med Sci, Seoul St Marys Hosp, Dept Dermatol,Coll Med, Seoul, South Korea; Wirye Seoul Doctors Hosp, Seongnam, South Korea; Seoul Natl Univ, Bundang Hosp, Dept Dermatol, Coll Med, Seongnam, South Korea; Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Coll Med, Seongnam, South Korea; Hallym Univ, Dongtan Sacred Heart Hosp, Dept Pediat, Coll Med, Hwaseong, South Korea; Korea Univ, Dept Dermatol, Coll Med, Seoul, South Korea; Vet Hlth Serv Med Ctr, Dept Dermatol, Seoul, South Korea; Kyung Hee Univ, Hosp Gangdong, Sch Med, Dept Pediat, Seoul, South Korea; Korea Univ, Coll Med, Dept Internal Med, Seoul, South Korea; Inha Univ, Sch Med, Dept Pediat, Incheon, South Korea; Ajou Univ, Sch Med, Dept Allergy & Clin Immunol, 164 Worldcup Ro, Suwon 16499, South Korea; Catholic Univ Korea, Seoul St Marys Hosp, Dept Dermatol, Coll Med, 222 Banpo Daero, Seoul 06591, South Korea Chang, Yoon-Seok/J-5628-2012; Kim, Dae/AAJ-7518-2021; Kim, Hyun/D-5568-2011; Kim, Su Hyun/JPY-2079-2023; Kim, Ju-Hyoung/N-1450-2019; Kang, Sung-Yoon/AAG-7523-2020; Lee, Seung Eun/ABG-1607-2021; Lee, Young Bok/AAZ-6426-2021; Park, Han-Ki/AAY-3102-2020; Kim, Hye/AAF-7609-2020; LEE, YOUNG BOK/AAZ-6426-2021; Kim, Hak-Jae/Q-9368-2019; Kim, Byung-Keun/N-4256-2018; Kim, Yong-Tae/HQZ-0240-2023; Kim, Juhee/KFS-3069-2024; Park, Kui Young/JVM-7652-2024; Lee, Dong Hun/AAS-6021-2021; Youn, Sang/J-5558-2012; Kim, Gou/AAI-1109-2020 7501395695; 55649570908; 37062104600; 7402093768; 57204538197; 57202669769; 56192953300; 38260929400; 58045929900; 36608393400; 36666447400; 35102450900; 57196356574; 57203326373; 57191685789; 56703907300; 8659715100; 57191720302; 55429683200; 57035517300; 23020014500; 57218664064; 23103922300; 57210714585; 15724462400; 7402443711; 56735321800; 57202327298; 36066866100; 8413361800; 57190277285; 56045433800; 8903096500; 55712986100; 26537543200; 7202411345; 35102158500; 55736569100; 7004193730; 8409118500; 13405438300; 55356320800 ye9007@ajou.ac.kr;yymmpark6301@hotmail.com; ALLERGY ASTHMA & IMMUNOLOGY RESEARCH ALLERGY ASTHMA IMMUN 2092-7355 2092-7363 12 5 SCIE ALLERGY;IMMUNOLOGY 2020 5.764 29.3 0.49 2025-06-25 19 20 Urticaria; antihistamine, treatment; guideline; evidence; leukotriene; IgE; cyclosporine CHRONIC IDIOPATHIC URTICARIA; BAND ULTRAVIOLET-B; QUALITY-OF-LIFE; REFRACTORY CHRONIC URTICARIA; CYCLOSPORINE-A; DOUBLE-BLIND; OMALIZUMAB THERAPY; DOSE OMALIZUMAB; EFFICACY; ANTIHISTAMINE Antihistamine; Cyclosporine; Evidence; Guideline; IgE; Leukotriene; Treatment; Urticaria cyclosporine; dapsone; histamine H1 receptor antagonist; immunomodulating agent; leukotriene receptor blocking agent; methotrexate; omalizumab; add on therapy; chronic urticaria; drug efficacy; drug megadose; drug safety; evidence based practice; human; phototherapy; practice guideline; Review; symptom English 2020 2020-09 10.4168/aair.2020.12.5.750 바로가기 바로가기 바로가기 바로가기
Article Effect of Multi-Pass Caliber Rolling on Dilute Extruded Mg-Bi-Ca Alloy A Mg-1.32Bi-0.72Ca (BX11) alloy having bimodal grain structure was successfully prepared by a novel processing route of combining extrusion and three-pass caliber rolling. The first extruded and then caliber-rolled (E-CRed) alloy demonstrates a necklace-like grain structure with ultrafine grains formed around the microscale deformed grains, which is remarkably different from the uniform microstructure of the as-extruded alloy. In addition, the E-CRed BX11 alloy exhibits strong basal texture which is mainly original from the microscale deformed grains. Furthermore, the E-CRed BX11 alloy demonstrates excellent comprehensive mechanical properties, with an ultra-high yield strength of 351 MPa and a good elongation to failure of 13.2%. The significant strength improvement can be mainly attributed to the significant grain refinement and much stronger basal texture compared with the as-extruded sample. Meng, Shuaiju; Yu, Hui; Han, Haisheng; Feng, Jianhang; Huang, Lixin; Dong, Lishan; Nan, Xiaolong; Li, Zhongjie; Park, Sung Hyuk; Zhao, Weimin Hebei Univ Technol, Sch Mat Sci & Engn, Tianjin 300130, Peoples R China; Korea Inst Mat Sci, Magnesium Dept, Chang Won 51508, South Korea; Tianjin Key Lab Mat Laminating Fabricat & Interfa, Tianjin 300130, Peoples R China; CITIC Dicastal Co LTD, Qin Huangdao 066011, Hebei, Peoples R China; China Acad Engn Phys, Inst Fluid Phys, Natl Key Lab Shock Wave & Detonat Phys, Mianyang 621999, Sichuan, Peoples R China; Shannghai Jiao Tong Univ, Sch Mat Sci & Engn, Shuanghai 200240, Peoples R China; Kyungpook Natl Univ, Sch Mat Sci & Engn, Daegu 41566, South Korea Huang, Hongwen/AAD-6853-2020; Park, Sung-Hyuk/AAE-6726-2022; Li, Zhongjie/J-1474-2018; Zhao, Weimin/I-6153-2016; yu, hui/H-8481-2012; Yu, Hui/H-8481-2012 57190763504; 7405855938; 57215010214; 57201554256; 57215233280; 57214990135; 54890574200; 57204626991; 54786002500; 55725938100 shuaijumeng@163.com;yuhuidavid@126.com;hanhaisheng@hebut.edu.cn;13933765819@126.com;huanglixin@dicastal.com;donglishan1991@163.com;Nanxl@caep.cn;lizhongjie1993@126.com;sh.park@knu.ac.kr;wmzhao@hebut.edu.cn; METALS METALS-BASEL 2075-4701 10 3 SCIE MATERIALS SCIENCE, MULTIDISCIPLINARY;METALLURGY & METALLURGICAL ENGINEERING 2020 2.351 29.4 0.22 2025-06-25 4 4 Mg-Bi-Ca; mechanical property; bimodal microstructure ACHIEVING HIGH-STRENGTH; ULTRA-HIGH STRENGTH; MECHANICAL-PROPERTIES; TENSILE PROPERTIES; MAGNESIUM ALLOYS; GRAIN-SIZE; MICROSTRUCTURE; DUCTILITY; TEMPERATURE; FABRICATION Bimodal microstructure; Mechanical property; Mg-Bi-Ca English 2020 2020-03 10.3390/met10030332 바로가기 바로가기 바로가기 바로가기
Article Heterogeneous Material Additive Manufacturing for Hot-Stamping Die Additive manufacturing (AM) has recently been receiving global attention. As an innovative alternative to existing manufacturing technologies, AM can produce three-dimensional objects from various materials. In the manufacturing industry, AM improves production cost, time, and quality in comparison to existing methods. In addition, AM is applied in the fabrication and production of objects in diverse fields. In particular, metal AM has been continuously commercialized in high value-added industries such as aerospace and health care by many research and development projects. However, the applicability of metal AM to the mold and die industry and other low value-added industries is limited because AM is not as economical as current manufacturing technologies. Therefore, this paper proposes an effective solution to the problem. This study examines a method for using direct energy deposition and heterogeneous materials, a heterogeneous material additive-manufacturing process for metals used to optimize the cooling channels and a key process in manufacturing hot-stamping dies. The improvements in the cooling performances and uniform cooling were evaluated by heat-flow analysis in a continuous process. Finally, trial products were fabricated using the proposed method, and a trial for hot stamping was conducted to examine the possibility of it being used in commercial applications. Hong, Myoung-Pyo; Kim, Jin-Jae; Kim, Woo-Sung; Lee, Min-Kyu; Bae, Ki-Man; Kim, Young-Suk; Sung, Ji-Hyun Korea Inst Ind Technol, Extreme Fabricat Technol Grp, 320 Techno Sunhwan Ro, Dalseong Gun 711883, Daegu, South Korea; Kyungpook Natl Univ, Sch Mech Engn, Daugu 41566, South Korea; IL GI TECH CO LTD, Precedence Dev Team, 50 Gongdan4 Ro, Gyeongsanbuk Do 712883, Gyeongsan Si, South Korea Park, Jun/HPH-3570-2023; Lee, Jinwoo/P-2493-2018 57192270657; 57209555877; 57200625190; 57218901564; 57200625331; 36065820800; 23482644100 mp77@kitech.re.kr;jinjaekim@knu.ac.kr;kws0629@kitech.re.kr;dlalsrb@kitech.re.kr;tank5346@nate.com;caekim@knu.ac.kr;jsung@kitech.re.kr; METALS METALS-BASEL 2075-4701 10 9 SCIE MATERIALS SCIENCE, MULTIDISCIPLINARY;METALLURGY & METALLURGICAL ENGINEERING 2020 2.351 29.4 0.44 2025-06-25 5 8 additive manufacturing; cooling channel system; direct energy deposition; functional metal powder; hot-stamping die DEPOSITION; ENERGY; TOOL; COMPONENTS Additive manufacturing; Cooling channel system; Direct energy deposition; Functional metal powder; Hot-stamping die English 2020 2020-09 10.3390/met10091210 바로가기 바로가기 바로가기 바로가기
Article RSM and BPNN Modeling in Incremental Sheet Forming Process for AA5052 Sheet: Multi-Objective Optimization Using Genetic Algorithm In this study, the response surface method (RSM), back propagation neural network (BPNN), and genetic algorithm (GA) were used for modeling and multi-objective optimization of the forming parameters of AA5052 in incremental sheet forming (ISF). The optimization objectives were maximum forming angle and minimum thickness reduction whose values vary in response to changes in production process parameters, such as the tool diameter, step depth, tool feed rate, and tool spindle speed. A Box-Behnken experimental design was used to develop an RSM and BPNN model for modeling the variations in the forming angle and thickness reduction in response to variations in process parameters. Subsequently, the RSM model was used as the fitness function for multi-objective optimization of the ISF process using the GA. The results showed that RSM effectively modeled the forming angle and thickness reduction. Furthermore, the correlation coefficients of the experimental responses and BPNN predictions of the experiment results were good with the minimum value being 0.97936. The Pareto optimal solutions for maximum forming angle and minimum thickness reduction were obtained and reported. The optimized Pareto front produced by the GA can be a rational design guide for practical applications of AA5052 in the ISF process. Xiao, Xiao; Kim, Jin-Jae; Hong, Myoung-Pyo; Yang, Sen; Kim, Young-Suk Kyungpook Natl Univ, Grad Sch, Daegu 41566, South Korea; Korea Inst Ind Technol, Extreme Fabricat Technol Grp, Daegu 711883, South Korea; AAC Commun Technol, Changzhou 213001, Jiangsu, Peoples R China; Kyungpook Natl Univ, Sch Mech Engn, Daegu 41566, South Korea Kim, Sang-Hoon/AAA-2248-2020 57195394085; 57209555877; 57192270657; 57211837796; 36065820800 xiaoye012512@knu.ac.kr;jinjaekim@knu.ac.kr;mp77@kitech.re.kr;YangSen@aactechnologies.com;caekim@knu.ac.kr; METALS METALS-BASEL 2075-4701 10 8 SCIE MATERIALS SCIENCE, MULTIDISCIPLINARY;METALLURGY & METALLURGICAL ENGINEERING 2020 2.351 29.4 0.88 2025-06-25 20 23 incremental sheet forming; RSM; BP neural network; genetic algorithm; multi-objective optimization SINGLE-POINT; PROCESS PARAMETERS; FORMABILITY; ANN BP neural network; Genetic algorithm; Incremental sheet forming; Multi-objective optimization; RSM English 2020 2020-08 10.3390/met10081003 바로가기 바로가기 바로가기 바로가기
Article Gold Nanoparticle-Enhanced and Roll-to-Roll Nanoimprinted LSPR Platform for Detecting Interleukin-10 Localized surface plasmon resonance (LSPR) is a powerful platform for detecting biomolecules including proteins, nucleotides, and vesicles. Here, we report a colloidal gold (Au) nanoparticle-based assay that enhances the LSPR signal of nanoimprinted Au strips. The binding of the colloidal Au nanoparticle on the Au strip causes a red-shift of the LSPR extinction peak, enabling the detection of interleukin-10 (IL-10) cytokine. For LSPR sensor fabrication, we employed a roll-to-roll nanoimprinting process to create nanograting structures on polyethylene terephthalate (PET) film. By the angled deposition of Au on the PET film, we demonstrated a double-bent Au structure with a strong LSPR extinction peak at similar to 760 nm. Using the Au LSPR sensor, we developed an enzyme-linked immunosorbent assay (ELISA) protocol by forming a sandwich structure of IL-10 capture antibody/IL-10/IL-10 detection antibody. To enhance the LSPR signal, we introduced colloidal Au nanocube (AuNC) to be cross-linked with IL-10 detection antibody for immunogold assay. Using IL-10 as a model protein, we successfully achieved nanomolar sensitivity. We confirmed that the shift of the extinction peak was improved by 450% due to plasmon coupling between AuNC and Au strip. We expect that the AuNC-assisted LSPR sensor platform can be utilized as a diagnostic tool by providing convenient and fast detection of the LSPR signal. Baek, Seung Hee; Song, Hyun Woo; Lee, Sunwoong; Kim, Jung-Eun; Kim, Yeo Hyang; Wi, Jung-Sub; Ok, Jong G.; Park, Jun Seok; Hong, Seonki; Kwak, Moon Kyu; Lee, Hye Jin; Nam, Sung-Wook Kyungpook Natl Univ, Sch Med, Dept Mol Med, Daegu, South Korea; Kyungpook Natl Univ, Sch Mech Engn, Dept Mech Engn, Daegu, South Korea; Kyungpook Natl Univ, Sch Med, Dept Pediat, Daegu, South Korea; Korea Res Inst Stand & Sci, Ctr Nanobio Measurement, Daejeon, South Korea; Seoul Natl Univ Sci & Technol, Dept Mech & Automot Engn, Seoul, South Korea; Kyungpook Natl Univ, Sch Med, Dept Surg, Daegu, South Korea; Daegu Gyeongbuk Inst Sci & Technol DGIST, Dept Emerging Mat Sci, Daegu, South Korea; Kyungpook Natl Univ, Dept Chem, Daegu, South Korea; Kyungpook Natl Univ, Green Nano Mat Res Ctr, Daegu, South Korea Kwak, Moon/AGQ-6058-2022; LEE, HYEJIN/W-1345-2018; Ok, Jong/B-2509-2010; Ok, Jong G./B-2509-2010; Park, Joonhong/AAZ-9885-2020; Nam, Sung-Wook/V-5519-2019 57203346671; 57212219196; 57215897149; 57209054588; 57032023800; 8326663000; 16480899100; 35226761100; 37461264400; 57203947984; 56569175200; 16167127700 mkkwak@knu.ac.kr;hyejinlee@knu.ac.kr;nams@knu.ac.kr; FRONTIERS IN CHEMISTRY FRONT CHEM 2296-2646 8 SCIE CHEMISTRY, MULTIDISCIPLINARY 2020 5.221 29.5 1.24 2025-06-25 25 26 Au nanocube; IL-10; Au LSPR strip; roll-to-roll; nanoarchitecture SURFACE-PLASMON RESONANCE; RANGE Au LSPR strip; Au nanocube; IL-10; nanoarchitecture; roll-to-roll English 2020 2020-05-26 10.3389/fchem.2020.00285 바로가기 바로가기 바로가기 바로가기
Article An accelerated rendering scheme for massively large point cloud data In the field of large-scale data visualization, the graphics rendering speed is one of the most important factors for its application development. Since the large-scale data visualization usually requires three-dimensional representations, the three-dimensional graphics libraries such as OpenGL and DirectX have been widely used. In this paper, we suggest a new way of accelerated rendering, through directly using the direct rendering manager packets. Current three-dimensional graphics features are focused on the efficiency of general purpose rendering pipelines. In contrast, we concentrated on the speed-up of the special-purpose rendering pipeline, for point cloud rendering. Our result shows that we achieved our purpose effectively. Baek, Nakhoon; Yoo, Kwan-Hee Kyungpook Natl Univ, Sch Comp Sci & Engn, Daegu 41566, South Korea; Chungbuk Natl Univ, Dept Comp Sci, Cheongju 28644, Chungbuk, South Korea 7007017954; 8859846800 oceancru@gmail.com;khyoo@cbnu.ac.kr; JOURNAL OF SUPERCOMPUTING J SUPERCOMPUT 0920-8542 1573-0484 76 10 SCIE COMPUTER SCIENCE, HARDWARE & ARCHITECTURE;COMPUTER SCIENCE, THEORY & METHODS;ENGINEERING, ELECTRICAL & ELECTRONIC 2020 2.474 29.6 0.14 2025-06-25 2 4 Large-scale data visualization; Direct rendering manager; Graphics acceleration; Point rendering Direct rendering manager; Graphics acceleration; Large-scale data visualization; Point rendering Application programming interfaces (API); Data visualization; Managers; Pipelines; Three dimensional computer graphics; Visualization; Dimensional representation; Direct renderings; Graphics rendering; ITS applications; Large-scale data visualization; Point rendering; Rendering pipelines; Three-dimensional graphics; Rendering (computer graphics) English 2020 2020-10 10.1007/s11227-019-03114-y 바로가기 바로가기 바로가기 바로가기
Article An emulation scheme for OpenGL SC 2.0 over OpenGL OpenGL SC (OpenGL for Safety Critical) is the safety-critical variation of the famous OpenGL 3D graphics library. The latest version of OpenGL SC was on release in the year of 2016, as the OpenGL SC 2.0. To provide the full features of this new standard, we need its new implementations. As the first step, we here present the way of emulating it over the widely used desktop OpenGL. It is the first literature on the implementation of the new graphics standard, at least to the best of our knowledge. We present the detailed analysis and design of the emulator. Baek, Nakhoon Kyungpook Natl Univ, Sch Comp Sci & Engn, Daegu 41566, South Korea; Kyungpook Natl Univ, Software Technol Res Ctr, Daegu 41566, South Korea; Dassomeycom Inc, Daegu 41566, South Korea 7007017954 oceancru@gmail.com; JOURNAL OF SUPERCOMPUTING J SUPERCOMPUT 0920-8542 1573-0484 76 10 SCIE COMPUTER SCIENCE, HARDWARE & ARCHITECTURE;COMPUTER SCIENCE, THEORY & METHODS;ENGINEERING, ELECTRICAL & ELECTRONIC 2020 2.474 29.6 0.22 2025-06-25 5 5 OpenGL SC 2; 0; Emulation; Desktop OpenGL GRAPHICS Desktop OpenGL; Emulation; OpenGL SC 2.0 Application programming interfaces (API); Safety engineering; 3D graphics libraries; Desktop OpenGL; Emulation; Opengl sc; Computer graphics English 2020 2020-10 10.1007/s11227-018-2399-1 바로가기 바로가기 바로가기 바로가기
Editorial Material Editor's note Kumar, Karthigai; Bhuiyan, Md Zakirul Alam; Paul, Anand; Chen, Joy Iong-Zong Karpagam Coll Engn, Coimbatore, Tamil Nadu, India; Fordham Univ, Bronx, NY 10458 USA; Kyungpook Natl Univ, Daegu, South Korea; Da Yeh Univ, Dacun, Changhua, Taiwan Bhuiyan, Zakirul/AAJ-1930-2020 karthigaikumar@kce.ac.in;mbhuiyan3@fordham.edu;paul.editor@gmail.com;jchen@mail.dyu.edu.tw; JOURNAL OF SUPERCOMPUTING J SUPERCOMPUT 0920-8542 1573-0484 76 5 SCIE COMPUTER SCIENCE, HARDWARE & ARCHITECTURE;COMPUTER SCIENCE, THEORY & METHODS;ENGINEERING, ELECTRICAL & ELECTRONIC 2020 2.474 29.6 0 English 2020 2020-05 10.1007/s11227-020-03277-z 바로가기 바로가기 바로가기
페이지 이동:

논문 데이터 용어 설명

용어 설명
WoS Web of Science. Clarivate Analytics에서 제공하는 학술 데이터베이스입니다. 해당 논문이 WoS에 수록되어 있는지 여부를 표시합니다 (○: 수록됨).
SCOPUS Elsevier에서 제공하는 세계 최대 규모의 초록 및 인용 데이터베이스입니다. 해당 논문이 SCOPUS에 수록되어 있는지 여부를 표시합니다 (○: 수록됨).
Document Type 문헌의 유형을 나타냅니다. Article(원저), Review(리뷰), Proceeding Paper(학회논문), Editorial Material(편집자료), Letter(레터) 등으로 분류됩니다.
Title 논문의 제목입니다.
Abstract 논문의 초록(요약)입니다. 연구의 목적, 방법, 결과, 결론을 간략히 요약한 내용입니다.
Authors 논문의 저자 목록입니다. 공동 저자가 여러 명인 경우 세미콜론(;)으로 구분됩니다.
Affiliation 저자들의 소속 기관 정보입니다. 대학, 연구소, 기업 등 저자가 소속된 기관명이 표시됩니다.
ResearcherID (WoS) Web of Science의 고유 연구자 식별번호입니다. 동명이인을 구분하고 연구자의 업적을 정확하게 추적할 수 있습니다.
AuthorsID (SCOPUS) SCOPUS의 고유 저자 식별번호입니다. 연구자의 모든 출판물을 추적하고 관리하는 데 사용됩니다.
Journal 논문이 게재된 학술지의 정식 명칭입니다.
JCR Abbreviation Journal Citation Reports에서 사용하는 저널의 공식 약어입니다. 저널을 간략하게 표기할 때 사용됩니다.
ISSN International Standard Serial Number. 국제표준연속간행물번호로, 인쇄본 저널에 부여되는 고유 식별번호입니다.
eISSN Electronic ISSN. 전자 버전 저널에 부여되는 고유 식별번호입니다.
Volume 저널의 권(Volume) 번호입니다. 보통 연도별로 하나의 권이 부여됩니다.
Issue 저널의 호(Issue) 번호입니다. 한 권 내에서 여러 호로 나누어 출판되는 경우가 많습니다.
WoS Edition Web of Science의 에디션입니다. SCIE(Science Citation Index Expanded), SSCI(Social Sciences Citation Index), AHCI(Arts & Humanities Citation Index) 등으로 구분됩니다.
WoS Category Web of Science의 주제 분류 카테고리입니다. 저널과 논문이 속한 학문 분야를 나타냅니다.
JCR Year 해당 저널의 JCR(Journal Citation Reports) 지표가 산출된 연도입니다.
IF (Impact Factor) 저널 영향력 지수. 최근 2년간 발표된 논문이 해당 연도에 평균적으로 인용된 횟수를 나타냅니다. 저널의 학술적 영향력을 나타내는 대표적인 지표입니다.
JCR (%) 해당 카테고리에서 저널이 위치하는 상위 백분율입니다. 값이 낮을수록 우수한 저널임을 의미합니다 (예: 5%는 상위 5%를 의미).
FWCI Field-Weighted Citation Impact. 분야별 가중 인용 영향력 지수입니다. 논문이 받은 인용을 동일 분야, 동일 연도, 동일 문헌 유형의 평균과 비교한 값입니다. 1.0이 평균이며, 1.0보다 높으면 평균 이상의 인용을 받았음을 의미합니다.
FWCI UpdateDate FWCI 값이 마지막으로 업데이트된 날짜입니다. FWCI는 인용이 누적됨에 따라 주기적으로 업데이트됩니다.
WOS Citation Web of Science에서 집계된 해당 논문의 총 인용 횟수입니다.
SCOPUS Citation SCOPUS에서 집계된 해당 논문의 총 인용 횟수입니다.
Keywords (WoS) 저자가 논문에서 직접 지정한 키워드입니다. Web of Science에 등록된 저자 키워드 목록입니다.
KeywordsPlus (WoS) Web of Science에서 자동으로 추출한 추가 키워드입니다. 논문의 참고문헌 제목에서 자주 등장하는 단어들로 생성됩니다.
Keywords (SCOPUS) 저자가 논문에서 직접 지정한 키워드입니다. SCOPUS에 등록된 저자 키워드 목록입니다.
KeywordsPlus (SCOPUS) SCOPUS에서 자동으로 추출하거나 추가한 색인 키워드입니다.
Language 논문이 작성된 언어입니다. 대부분 English이며, 그 외 다양한 언어로 작성된 논문이 포함될 수 있습니다.
Publication Year 논문이 출판된 연도입니다.
Publication Date 논문의 정확한 출판 날짜입니다 (년-월-일 형식).
DOI Digital Object Identifier. 디지털 객체 식별자로, 논문을 고유하게 식별하는 영구적인 식별번호입니다. 이를 통해 논문의 온라인 위치를 찾을 수 있습니다.